FDA OKs First Treatment for Chronic Hepatitis D Infection
Chronic hepatitis delta virus (HDV) infection has its first FDA-approved treatment, after the agency granted accelerated approval to bulevirtide (Hepcludex) ...
Doctors Warn Social Media Poses Smoking-Level Health Risk
The Academy of Medical Royal Colleges has called for routine clinical screening of children's social media use in evidence to ...
EU Panel Backs Wider Uses for Cancer Drugs
The EMA has backed new and expanded uses for multiple cancer drugs, signaling a push toward biomarker-driven, earlier-line care. Medscape ...
Weight Loss Alone May Not Prevent T2D in Some Patients
Prediabetes management often emphasizes weight loss, but a long-term follow-up study found that for some older adults, thinner isn’t always ...
FIFA, We Have a Problem
On the heels of the annual World Health Assembly in Geneva, let us quickly review today's public health scoreboard as ...
Gender Pay Gap a Problem in Pediatrics, AAP Policy Statement Says
Pervasive gender-based pay inequities in medicine particularly impact an increasingly female pediatric workforce, according to a new policy statement from ...
New First-Line Option Approved in Triple-Negative Breast Cancer
The FDA on Friday approved datopotamab deruxtecan (Dato-DXd; Datroway) as a first-line option for unresectable or metastatic triple-negative breast cancer ...
Food Preservatives and CVD; Keto Diet Study Retracted; Impella Controller Errors
Food preservatives had substantial ties with hypertension and cardiovascular diseases, according to a cohort study. (European Heart Journal) Meanwhile, stand-out ...
‘Things That Had Never Been Tried’: American Clinicians on Treating Ebola in 2014
Aneesh Mehta, MD, was the physician on call when the first Ebola patient arrived at Emory University Hospital on Aug. ...
Botulinum Toxin for Frown Lines Moves Toward EU Approval
EMA advisers have backed a botulinum toxin for moderate to severe frown lines in adults, with reported onset of action ...
Europe Moves Closer to New Retinal Disease Biosimilar
A new anti-VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization. Medscape News ...
AI Decision Support in ED: Helpful Tool or Clinical Risk?
Research shows artificial intelligence has use in the emergency department, but how it’s implemented is key. Medscape Medical News Source ...
How a radical new view of life could reveal its origin – and aliens
Wherever you are reading this, look around you. Every living thing you can see – other people, pets, birds flying ...
FDA Staff Blindsided by Move Allowing More E-Cigs, Nicotine Pouches Onto Market
Senior officials in the FDA's tobacco center were blindsided by a recent decision that opens the door to allowing more ...
EU Supports Anti-Inflammatory for Secondary Heart Risk
The European Medicine Agency has recommended marketing authorization for a hybrid colchicine medicine for secondary prevention of atherothrombotic events in ...
Cataract Surgery: 4 Things You Might Not Know
From mythical thorn bushes to flying aces, the remarkable history of one of medicine’s most routine procedures. Medscape Medical News ...
Investigational Drug Lowers Tourette Relapse Risk in Kids
Investigational ecopipam lowered relapse risk in pediatric Tourette patients compared with placebo over 24 weeks.Common side effects in the phase ...
More People Being Monitored at Home for Potential Hantavirus Exposure
States are monitoring additional people for potential hantavirus exposure, in many cases due to air travel, MedPage Today has learned. ...
US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant
Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest ...
Dexcom Warns Patients as Stolen Glucose Sensors Hit the Market
Medical device maker Dexcom said on Tuesday some of its glucose sensors slated for destruction were instead stolen and sold, ...
